Citation: Dh. Peters et Kl. Goa, OM-8980 - AN INITIAL REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN RHEUMATOID-ARTHRITIS, CLINICAL IMMUNOTHERAPEUTICS, 2(1), 1994, pp. 65-77
Citation: R. Whittington et Kl. Goa, IDARUBICIN - A PHARMACOECONOMIC EVALUATION OF ITS USE IN ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA (VOL 4, PG 287, 1993), PharmacoEconomics, 6(3), 1994, pp. 248-248
Citation: Mi. Wilde et al., ENALAPRIL - A REVIEW OF QUALITY-OF-LIFE AND PHARMACOECONOMIC ASPECTS OF ITS USE IN HEART-FAILURE AND MILD-TO-MODERATE HYPERTENSION, PharmacoEconomics, 6(2), 1994, pp. 155-182
Citation: Kl. Goa et Hm. Bryson, RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RGM-CSF) - AN APPRAISAL OF ITS PHARMACOECONOMIC STATUS IN NEUTROPENIA ASSOCIATED WITH CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT, PharmacoEconomics, 5(1), 1994, pp. 56-77
Citation: Kl. Dechant et Kl. Goa, CALCITRIOL - A REVIEW OF ITS USE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS AND ITS POTENTIAL IN CORTICOSTEROID-INDUCED OSTEOPOROSIS, Drugs & aging, 5(4), 1994, pp. 300-317
Citation: Kl. Goa et D. Faulds, VINORELBINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICALUSE IN CANCER-CHEMOTHERAPY, Drugs & aging, 5(3), 1994, pp. 200-234
Citation: Pe. Battershill et al., STREPTOKINASE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACYIN ACUTE MYOCARDIAL-INFARCTION IN OLDER PATIENTS, Drugs & aging, 4(1), 1994, pp. 63-86
Citation: Gl. Plosker et Kl. Goa, CLODRONATE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN RESORPTIVE BONE-DISEASE, Drugs, 47(6), 1994, pp. 945-982
Citation: Kl. Goa et P. Benfield, HYALURONIC-ACID - A REVIEW OF ITS PHARMACOLOGY AND USE AS A SURGICAL AID IN OPHTHALMOLOGY, AND ITS THERAPEUTIC POTENTIAL IN JOINT DISEASE AND WOUND-HEALING, Drugs, 47(3), 1994, pp. 536-566
Citation: Aj. Wagstaff et al., ACYCLOVIR - A REAPPRAISAL OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY, Drugs, 47(1), 1994, pp. 153-205
Citation: R. Whittington et Kl. Goa, IDARUBICIN - A PHARMACOECONOMIC EVALUATION OF ITS USE IN ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA, PharmacoEconomics, 4(4), 1993, pp. 287-307
Citation: Jw. Steele et al., EPALRESTAT - A REVIEW OF ITS PHARMACOLOGY, AND THERAPEUTIC POTENTIAL IN LATE-ONSET COMPLICATIONS OF DIABETES-MELLITUS, Drugs & aging, 3(6), 1993, pp. 532-555
Citation: Kl. Goa et Em. Sorkin, GABAPENTIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN EPILEPSY, Drugs, 46(3), 1993, pp. 409-427
Citation: Kl. Goa et Rn. Brogden, PROPIRAM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND CLINICAL USE AS AN ANALGESIC, Drugs, 46(3), 1993, pp. 428-445
Citation: D. Faulds et al., CYCLOSPORINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN IMMUNOREGULATORY DISORDERS, Drugs, 45(6), 1993, pp. 953-1040